Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/23/2025

Management of Thalassemia Minor in Pregnancy

Initial Assessment and Screening

  • Pregnant women with thalassemia minor should receive low-dose iron supplementation (30 mg/day) starting at the first prenatal visit, but avoid therapeutic iron doses unless true iron deficiency is confirmed, as their anemia is genetic and will not respond to iron therapy, according to the Centers for Disease Control and Prevention 1, 2
  • Screen for anemia at the first prenatal visit using hemoglobin concentration or hematocrit, applying pregnancy-specific anemia criteria for each trimester, as recommended by the Centers for Disease Control and Prevention 1
  • Recognize that women of Mediterranean, African, or Southeast Asian ancestry with mild anemia unresponsive to iron therapy likely have thalassemia minor rather than iron deficiency, as suggested by the Centers for Disease Control and Prevention 1, 2
  • Obtain baseline complete blood count, MCV, RDW, and serum ferritin to distinguish thalassemia minor from iron deficiency anemia, according to the Centers for Disease Control and Prevention 1, 3

Iron Supplementation Strategy

  • Start with prophylactic low-dose iron (30 mg/day) at the first prenatal visit, not therapeutic doses, as recommended by the Centers for Disease Control and Prevention 1, 2, 3
  • Do not escalate to therapeutic iron doses (60-120 mg/day) in thalassemia minor patients, as their anemia will not respond to iron therapy, according to the Centers for Disease Control and Prevention 1, 2
  • If anemia fails to respond after 4 weeks of iron supplementation despite compliance, perform further evaluation with MCV, RDW, and serum ferritin to confirm thalassemia minor diagnosis, as suggested by the Centers for Disease Control and Prevention 1, 2, 3

Key Clinical Pitfalls to Avoid

  • The most common error is treating thalassemia minor anemia with therapeutic iron doses (60-120 mg/day), which provides no benefit and may cause iron overload, according to the Centers for Disease Control and Prevention 1, 2
  • Do not refer for further evaluation solely based on mild anemia if the patient has confirmed thalassemia minor and hemoglobin remains >9 g/dL, as recommended by the Centers for Disease Control and Prevention 1
  • Only refer to a physician familiar with anemia in pregnancy if hemoglobin falls below 9.0 g/dL or hematocrit below 27.0%, according to the Centers for Disease Control and Prevention 1, 3

Postpartum Management

  • Screen for anemia at 4-6 weeks postpartum using nonpregnant anemia criteria, as recommended by the Centers for Disease Control and Prevention 1, 2
  • Stop supplemental iron at delivery if no risk factors for iron deficiency are present, according to the Centers for Disease Control and Prevention 1, 2